🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCagriSema (amylin + semaglutide) — REDEFINE Phase 3 results Page 3

CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results

Dr.Martinez Thu, Mar 12, 2026 at 10:19 AM 20 replies 606 viewsPage 3 of 4
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 12, 2026 at 2:34 PM#11

Moderator note: Great discussion, everyone. Just a reminder to keep things civil and evidence-based.

Thread quality is excellent — keep it up. 👍

3 11PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Mar 12, 2026 at 2:51 PM#12

Slightly tangential to CagriSema (amylin + but Dr.AddMedPHL reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

15 21JenPlateau, SallyK_inj, CryptoCarl and 12 others
Reply Quote Save Share Report
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Mar 12, 2026 at 3:08 PM#13
HealthEcon_DC said:
Follow-up question: what labs did your doctor order to monitor this

This is exactly right. HealthEcon_DC articulated what I have been trying to explain to my friends for months. The CagriSema (amylin + aspect is what made the difference for me.

Last edited: Mar 12, 2026 at 4:08 PM
11 18BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TomTeleRx
Member
189
678
Feb 2025
Delaware
Mar 12, 2026 at 3:25 PM#14

Saving this for reference. Quality thread.

Last edited: Mar 12, 2026 at 4:25 PM
48 17HPLC_Greg, LibrarianMeg, bri_stats and 45 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Mar 12, 2026 at 3:42 PM#15

Adding my data to this CagriSema (amylin + discussion:

MetricBaselineMonth 4Month 6
Weight276 lbs246 lbs211 lbs
A1C7.0%6.2%5.2%
hsCRP5.03.01.0

Protocol: Tirzepatide 15mg/wk, resistance training 3x/wk, protein 1.3g/kg/day.

17 2cory_ATX, lori_vegas, Dr.PulmRoch and 14 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
Survodutide (GCG/GLP-1) — MASH and obesity trial results16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register